Aravive Inc - ESG Rating & Company Profile powered by AI
This page displays a zero-cost ESG report covering Aravive Inc. The Disclosure score covers seventeen United Nations Sustainable Development Goals including: 'No Poverty', 'Decent Work & Economic Growth' and 'Life on Land'. The analysis of Aravive Inc was prepared by All Street Sevva using cutting edge AI.
Aravive Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.0, social score of 5.3 and governance score of 4.6.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1412 | Vallon Pharmaceuticals Inc | 4.1 | High |
| 1412 | Vectura Group PLC | 4.1 | High |
| 1443 | Aravive Inc | 4.0 | High |
| 1443 | Adaptive Biotechnologies Corp | 4.0 | High |
| 1443 | Ascletis Pharma Inc | 4.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aravive Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aravive Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aravive Inc report the average age of the workforce?
Sign up for free to unlockDoes Aravive Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aravive Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aravive Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aravive Inc offer flexible work?
Sign up for free to unlockDoes Aravive Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aravive Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aravive Inc conduct supply chain audits?
Sign up for free to unlockDoes Aravive Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aravive Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aravive Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aravive Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aravive Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aravive Inc disclose water use targets?
Sign up for free to unlockDoes Aravive Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aravive Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aravive Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aravive Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aravive Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aravive Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aravive Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aravive Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aravive Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aravive Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aravive Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aravive Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aravive Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aravive Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aravive Inc disclose its waste policy?
Sign up for free to unlockDoes Aravive Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aravive Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aravive Inc disclose energy use targets?
Sign up for free to unlockDoes Aravive Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aravive Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aravive Inc
These potential risks are based on the size, segment and geographies of the company.
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics (Hong Kong) Limited to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.